3-Bromo-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 95.0%, 1g

(3r)-3-{[(tert-butoxy)carbonyl]amino}-4,4-dimethylpentanoic acid, 95+%, 250mg

1,2-Bis(pyridin-4-ylmethylene)hydrazine, 95%, 5g

ethyl (2-formylphenoxy)acetate, 99%, 25g

Hydroxyde de potassium, min 85%, Ph.Eur., en pastilles, 5 kg, emballage plastique.

5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)THIOPHENE-2-CARBOXYLIC ACID, 95.0%, 1g

2-Methylquinoline, 95.0%, 500g

6-Aminoundecane, 97%, 5g

4-Methylpyrimidine, 98.0%, 10g

2,5-Dichlorothiophene-3-carboxylic acid, 95.0%, 100g

Octadecanedioic acid mono-tert-butyl ester, 95.0%, 250mg

5-Amino-2-(pyrrolidin-1-yl)benzonitrile, 95.0%, 1g

1,3-Dimethyl-5-(morpholin-4-yl)-1h-pyrazole-4-carbaldehyde, 98+%, 500mg